The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for ...

Robert F. Kennedy Jr. is making moves that could affect immunization uptake and policy in the U.S., while Oracle submits a ...

Limiting mifepristone access, changing Title X rules and implementation of the Emergency Medical Treatment and Labor Act are ...

Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic ...

The Drug Enforcement Administration (DEA), in concert with other federal agencies, has taken various steps in the past few ...

If you’re a federal worker affected by the ongoing layoffs with information relevant to keeping our coverage updated, feel ...

CDC staff received an email this week telling them to avoid using more than a dozen terms or words -- including "health ...

The industry wants the ability to make bolder health claims and to get the government and private insurers to pay for its products — as they do FDA-approved drugs.

While it was set to become effective today (Feb. 25), the final rule is delayed until April 28, according to the Dept. of ...

Pharmaceutical companies are developing new weight-loss treatments that aim to shed the pounds while preserving muscle mass - ...